TY  - GEN
AU  - Cortes,Javier
AU  - Di Cosimo,Serena
AU  - Climent,Miguel A
AU  - Cortés-Funes,Hernán
AU  - Lluch,Ana
AU  - Gascón,Pere
AU  - Mayordomo,José I
AU  - Gil,Miguel
AU  - Benavides,Manuel
AU  - Cirera,Lluís
AU  - Ojeda,Belén
AU  - Rodríguez,César A
AU  - Trigo,José M
AU  - Vazquez,Josep
AU  - Regueiro,Pilar
AU  - Dorado,Juan F
AU  - Baselga,José
TI  - Nonpegylated liposomal doxorubicin (TLC-D99), paclitaxel, and trastuzumab in HER-2-overexpressing breast cancer: a multicenter phase I/II study
SN  - 1078-0432
PY  - 2009///0507
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Disease-Free Survival
KW  - Doxorubicin
KW  - Female
KW  - Genes, erbB-2
KW  - Heart Diseases
KW  - chemically induced
KW  - Humans
KW  - Middle Aged
KW  - Neoplasm Metastasis
KW  - Paclitaxel
KW  - Trastuzumab
KW  - Up-Regulation
N1  - Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/1078-0432.CCR-08-1113
ER  -